Dark Forest Capital Management »

Denali Therapeutics shares owned by Dark Forest Capital Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Dark Forest Capital Management from 13F filings

Historical chart of Dark Forest Capital Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Dark Forest Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Dark Forest Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $398k 28k 13.99
2025-06-30 $398k 28k 13.99
2025-03-31 $1.1M 81k 13.60
2024-12-31 $263k 13k 20.38
2021-12-31 $24k 529 45.37
2021-09-30 $30k 595 50.42
2021-06-30 $0 3 0.00

More positions owned by Dark Forest Capital Management

Loews Corp Common Stock (L)
Ishares Msci Brazil Etf Reit (EWZ)
Simon Property Group Common Stock (SPG)
Vanguard Ftse Emerging Marke Reit (VWO)
Ishares Msci India Etf Reit (INDA)
Capital One Financial Corp Common Stock (COF)
Booz Allen Hamilton Holdings Reit (BAH)
Goldman Sachs Group Common Stock (GS)
Walmart Common Stock (WMT)
Microsoft Corp Common Stock (MSFT)
Axis Capital Holdings Common Stock (AXS)
Cintas Corp Common Stock (CTAS)
Amazon.com Common Stock (AMZN)
Popular Common Stock (BPOP)
Ss Spdr S&p Biotech Etf Common Stock (XBI)

View all positions for Dark Forest Capital Management

Top funds holding Denali Therapeutics

BlackRock
Vanguard Group
Baillie Gifford & Co
FMR
T. Rowe Price Investment Management
Ubs Global Asset Management Americas
State Street Corporation
Temasek Holdings
Capital Research Global Investors
Baker Bros. Advisors
Alliancebernstein
Geode Capital Management
Crestline Management
Holocene Advisors
Point72 Asset Management

View all funds holding Denali Therapeutics